Leukoplakia, Oral
Information
- Disease name
- Leukoplakia, Oral
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03692325 | Active, not recruiting | Phase 2 | Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia | December 5, 2018 | August 30, 2024 |
| NCT00299195 | Completed | N/A | A Randomized Study of Sulindac in Oral Premalignant Lesions | February 23, 2006 | January 6, 2020 |
| NCT03239834 | Completed | Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making | September 7, 2017 | December 20, 2020 | |
| NCT05730855 | Completed | Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions | November 1, 2022 | January 23, 2023 | |
| NCT04858100 | Recruiting | N/A | Oral Potentially Malignant Disorders: Comparison Between Surgical Treatment and Wait and See Approach | September 1, 2020 | March 1, 2026 |
| NCT03939364 | Withdrawn | Phase 1 | This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions | January 2022 | May 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007972